193
Views
4
CrossRef citations to date
0
Altmetric
COLONIZATION ON CATHETER SURFACES OF IRRADIATED PATHOGENIC YEAST

Microbial colonization of irradiated pathogenic yeast to catheter surfaces: Relationship between adherence, cell surface hydrophobicity, biofilm formation and antifungal susceptibility. A scanning electron microscope analysis

, , , &
Pages 519-527 | Received 21 May 2014, Accepted 10 Feb 2015, Published online: 27 Apr 2015

References

  • Baillie GS, Douglas LJ. 1998. Effect of growth rate on resistance of Candida albicans biofilms to antifungal agents. Antimicrob Agents Chemother 42:1900–1905.
  • Baillie GS, Douglas LJ. 1999. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol 310:644–656.
  • Barton M. 1995. Tables of equivalent dose in 2 Gy fractions: A simple application of the linear quadratic formula. Int J Radiat Oncol Biol Phys 31:371–378.
  • Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. 1994. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 32: 452–456.
  • Busson-Mabillot S. 1971. Influence of chemical fixation on ultra- structures. I. Study on organtes ovarian follicle of a teleosteen. J Microscopie 12:317–348.
  • Chandra J, Kuhn DH, Mukherjee PK, Hoyer LL, McCormick T, Ghannoum MA. 2001. Biofilm formation by the fungal pathogen Candida albicans. Development, architecture, and drug resistance. J Bacteriol 83:5385–5394.
  • Dambroso D, Svidzinski TIE, Svidzinski AE, Dalalio MMO, Moliterno RA. 2009. Radiotherapy effect on frequency of Candida spp. and on virulence of C. albicans isolated from the oral cavity of head and neck cancer patients. J Basic Appl Pharm Sci 30:25–32.
  • Delgado-Capel M, Gabillo A, Elías L, Yébenes JC, Sauca G, Capdevila JA. 2012. Peripheral venous catheter-related bacteremia in a general hospital. Rev Esp Quimioter 25:129–133.
  • Denis F, Claire DF, Olivier M. 2010. Prevention of central venous catheter- related infection in the intensive care unit. Critical Care 14:212.
  • Ellepola ANB, Samaranayake LP. 2001. Investigative methods for studying the adhesion and cell surface hydrophobicity of Candida species: An overview. Microbial Ecol Health Dis 13:46–54.
  • Espinel-Ingroff A, Canton E, Peman J, Rinaldi MG, Fothergill AW. 2009. Comparison of 24-hour and 48-hour voriconazole MICs as determined by the Clinical and Laboratory Standards Institute broth microdilution method (M27–A3 document) in three laboratories: Results obtained with 2,162 clinical isolates of Candida spp. and other yeasts. J Clin Microbiol 47:2766–2771.
  • Farrag HA, Hussain AA, Salama MS, Mahmoud RR. 2002. Molecular analysis, antimicrobial resistance and biological properties contributing to pathogenicity in irradiated clinical isolates associated with urinary tract infection. Az J Microbiol 56:162–181.
  • Finkel JS, Mitchell AP. 2011. Genetic control of Candida albicans biofilm development. Nat Rev Microbiol 9:109–118.
  • Fisher F, Cook NB. 1998. Fundamentals of diagnostic mycology, Chapters 4 and 7. Philadelphia, PA: W.B. Saunders Company. pp 112–114, 196–230.
  • Grainger DW, van der Mei HC, Jutte PC, van den Dungen JJ, Schultz MJ, van der Laan BF, Zaat SA, Busscher HJ. 2013. Critical factors in the translation of improved antimicrobial strategies for medical implants and devices. Biomaterials 34:9237–9243.
  • Guilliermond A. 2003. Yeasts: Culture, identification, and microbiology. Wexford College Press.
  • Gunderson SM, Hoffman H, Ernst EJ, Pfaller MA, Kiepser ME. 2000. In-vitro pharmacodynamic characteristics of nystatin including time-kill and post antifungal effect. Antimicrob Agents Chemother 44:2887–2890.
  • Hasan F, Xess I, Wang X, Jain N, Fries BC. 2009. Biofilm formation in clinical Candida isolates and its association with virulence. Microbes Infect 11:753–761.
  • Ingham CJ, Boonstra S, Levels S, de Lange M, Meis JF, Schneeberger PM. 2012. Rapid susceptibility testing and microcolony analysis of Candida spp. cultured and imaged on porous aluminum oxide. PLoS One 7:e33818
  • Kilic D, Agalar C, Denkbas E, Agalar F, Ozturk E, Emirdogan M, Deveci O. 2006. The effectiveness of impregnation of graft with cefazolin in foreign body infection. Clin Microbiol Infect 12:839.
  • Kojic EM, Darouiche RO. 2004. Candida infections of medical devices. Clin Microbiol Rev 17:255–267.
  • Kriznik A, Bouillot M, Coulon J, Gaboriaud F. 2005. Morphological specificity of yeast and filamentous Candida albicans forms on surface properties. CR Biol 328:928–935.
  • Li X, Van Z, Xu J. 2003. Quantitative variation of biofilms among strains in natural populations of Candida albicans. Microbiology 149:353–362.
  • Marchese A, Gualco L, Bandettini R, Peri C, Pescetto L, Ricagni L, Cavallero A, Ossi MC, Debbia EA, Schito GC. 2006. Biofilm production in well characterized Candida spp. isolated in Italy during the period 2002–2005 from paediatric and adult patients. Clin Microbiol Infect 12(Suppl. 4):836.
  • Martinez LR, Bryan RA, Apostolidis C, Morgenstern A, Casadevall A, Dadachova E. 2006. Antibody-guided alpha radiation effectively damages fungal biofilms. Antimicrob Agents Chemother 50:2132–2136.
  • Maser MD, Powell TE, Philpott CW. 1967. Relationships among pH, osmolality, and concentration of fixative solutions. Biotechnic Histochem 42:175–182.
  • Merz WG, Roberts GD. 1996. Detection and recovery of fungi from clinical specimens. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. 6th ed. Washington, DC: American Society for Microbiology. pp 709–722.
  • Miles RS, Amyes SGB. 1996. Laboratory control of antimicrobial therapy. In: Collee JG, Fraser AG, Marmion BP, Simmons A, editors. International Student Edition. Mackie & McCartney, Practical Medical Microbiology, 14th ed. New York: Churchill Livingstone. pp 151–178.
  • Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolke RH. 1995. Manual of clinical microbiology, 7th ed. Washington: ASM, pp. 1773.
  • National Committee for Clinical Laboratory Standards (NCCLS). 2001. Performance standards for antimicrobial susceptibility testing: eleventh informational supplement. Document M100-S11. Wayne, PA: NCCLS.
  • O’Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. 2011. Healthcare Infection Control Practices Advisory Committee (HICPAC). Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52:e162–193.
  • Ortega M, Marco F, Soriano A, Almela M, Martinez JA, Lopez J, Pitart C, Mensa J. 2011. Candida species bloodstream infection: Epidemiology and outcome in a single institution from 1991 to 2008. J Hosp Infect 77:157–161.
  • Park JS, Kim JH, Nho YC, Kwon OH. 1998. Antibacterial activities of Acrylic acid grafted polypropylene fabric and its metallic salt. J Appl Polym Sci 69:2213–2220.
  • Pereira GH, Muller PR, Szeszs MW, Levin AS, Melhem MS. 2010. Five-year evaluation of bloodstream yeast infections in a tertiary hospital: The predominance of non-C. albicans Candida species. Med Mycol 48:839–842.
  • Peres-Bota D, Rodriguez-Villalobos H, Dimopoulos G, Melot C, Vincent JL. 2004. Potential risk factors for infection with Candida spp. in critically ill patients. Clin Microbiol Infect 10:550–555.
  • Perez C, Pauli M, Bazerque P. 1990. An antibiotic assay by the agar well diffusion method. Acta Biol Med Exp 15:113–115.
  • Peters G, Locci R, Pulverer G. 1982. Adherence and growth of coagulase-negative Staphylococci on surfaces of intravenous catheters. J Infect Dis 146:479–482.
  • Pfaller MA. 2012. Antifungal drug resistance: Mechanisms, epidemiology, and consequences for treatment. Am J Med 125:S3–13.
  • Rad AY, Ayhaman H, Kisa Ö, Piskin E. 2000. Hydrophobicities and electrostatic behavior of different micro-organisms. Turk J Biol 24:215–231.
  • Rajendran R, Robertson DP, Hodge PJ, Lappin DF, Ramage G. 2010. Hydrolytic enzyme production is associated with Candida albicans biofilm formation from patients with type 1 diabetes. Mycopathologia 170:229–235.
  • Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. 2005. Candida biofilms: An update. Eukaryotic Cell 4:633–638.
  • Rautemaa R, Ramage G. 2011. Oral candidosis – clinical challenges of a biofilm disease. Crit Rev Microbiol 37:328–336.
  • Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. 2005. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol:2155–2162.
  • Salama AA. 2004. The impact of silver sulfadiazine, benzalkonium chloride and chlorhexidine on the cell surface hydrophobicity of Candida albicans and Candida tropicalis. N Egypt J Microbiol 8:386–405.
  • Sardi J C, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJS. 2013. Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 62:10–24.
  • Shin JH, Kee SJ, Shin MG, Kim SH, Shin DH, Lee SK, Suh SP, Ryang DW. 2002. Biofilm production by isolates of Candida species recovered from non neutropenic patients: Comparison of bloodstream isolates with isolates from other sources. J Clin Microbiol 40:1244–1248.
  • Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J. 2011. Candida glabrata, Candida parapsilosis and Candida tropicalis: Biology, epidemiology, pathogenicity and anti-fungal resistance. FEMS Microbiol Rev 36:288–305.
  • Wingard JR. 1995. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 20:115–125.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.